Evidence map›Paper›PMID 42501226›Full record

ReviewNeuroscience bulletin2026

Deep Brain Stimulation for Disorders of Consciousness: From Mesocircuit Mechanisms to Circuit-Guided Precision Neuromodulation.

Di Zang, Keiko Hasuike, Zengxin Qi, Yanbing Yu, Peng Gui

Abstract readReview
In one paragraph

Review in Neuroscience bulletin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Di Zang *Department of Neurosurgery, China-Japan Friendship Hospital, Beijing, 100029, China. zangdizhbjig@126.com.ORCID http://orcid.org/0000-0003-1400-2747
Keiko Hasuike *Peking University China⁃Japan Friendship School of Clinical Medicine, Beijing, 100029, China.
Zengxin Qi *Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, 200040, China.
Yanbing YuDepartment of Neurosurgery, China-Japan Friendship Hospital, Beijing, 100029, China. yuyanbing123@126.com.ORCID http://orcid.org/0000-0002-7392-4840
Peng GuiInstitute of Neuroscience, Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, 200031, China. pgui@ion.ac.cn.ORCID http://orcid.org/0000-0002-9848-7050

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Disorders of consciousness (DoC) following severe brain injury represent a formidable clinical challenge, with limited therapeutic options for patients in prolonged unresponsive or minimally conscious states. Deep brain stimulation (DBS) of the central thalamus has re-emerged as a pivotal strategy to restore arousal and functional communication. In this review, we integrate systems neuroscience with clinical evidence to delineate the transition of DBS from an experimental intervention toward circuit-guided precision medicine. We first articulate the mesocircuit hypothesis, positing that DBS acts not by local excitation alone, but by reversing a circuit-level collapse driven by striatal deafferentation and excessive pallidal inhibition. Synthesizing recent clinical data, we highlight an emerging reinterpretation of targeting, in which efficacy may depend less on named anatomical nuclei than on the recruitment of preserved arousal conduits and fronto-striatal projections-a hypothesis supported by connectomic analyses but awaiting direct causal validation. Furthermore, we discuss the redefinition of patient selection through Cognitive Motor Dissociation (CMD) and the evolution of stimulation paradigms toward biomimetic, adaptive control policies (e.g., 40-60 Hz state-dependent modulation). Finally, we address the ethical framework of "consent under uncertainty" essential for responsible translation. We conclude that while heterogeneity remains a hurdle, combining connectome-based targeting with sensing-enabled technologies offers a viable roadmap to validate DBS as a standard of care for carefully selected patients.

Indexed as

BrainConsciousness DisordersDeep Brain StimulationAnimalsHumansThalamusAdaptive neuromodulationCentral thalamusConnectomicsDeep brain stimulationDisorders of consciousnessMesocircuit

Identifiers

PMID42501226
PMCPMC13545168

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.